Annexon, Inc. Share Price

Annexon, Inc. Share Price

NASDAQ: ANNX | Small Cap
$4.06
+$0.03 (0.87%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Annexon, Inc. Stock Performance

Open
$4.00
Prev. Close
$4.03
Circuit Range
N/A
Day Range
$3.87 - $4.08
Year Range
$2.54 - $7.16
Volume
1,82,336
Average Traded
$4.02

Annexon, Inc. Share Price Today

As of 31 October 2026, Annexon, Inc.'s share price is $4.06. The stock opened at $4.00, compared to its previous close of $4.03. During today's trading session, Annexon, Inc.'s share price traded between $3.87 and $4.08, with an average price of $3.98. Over the past 52 weeks, the stock has recorded a high of $7.16 and a low of $2.54. In terms of performance, Annexon, Inc.'s share price has declined by 30.83% over the last six months and is up 28.48% on a year-on-year basis.

Annexon, Inc. Share Price Chart

Line chart of the Annexon, Inc. price trend over the selected period. The price rose overall, ranging from 3.89 to 4.08, ending at 4.06.
$3.87$4.08
L
Show Current Price
H

Annexon, Inc. Stock Fundamentals & Key Indicators

Market Cap
$629.73M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.07
Revenue (TTM)
$0.00
Return On Equity (TTM)
-108.93%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-0.78%

Annexon, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$54.92-$48.26-$44.14-$55.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A12.13%8.54%-25.40%

Annexon, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$141.95-$134.24-$138.20-$208.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A5.43%-2.95%-50.90%

About Annexon, Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Annexon, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.22
$4.05
-4.27%
Sep 2026
$4.96
$4.24
-19.41%
Aug 2026
$5.06
$5.25
+3.04%
Jul 2026
$5.86
$5.10
-10.76%
Jun 2026
$5.64
$5.71
+5.64%
May 2026
$5.93
$5.41
-7.84%
Apr 2026
$5.72
$5.87
+5.77%
Mar 2026
$5.57
$5.55
-0.89%
Feb 2026
$6.18
$5.60
-10.18%
Jan 2026
$5.09
$6.24
+24.45%
Dec 2025
$4.42
$5.01
+11.09%
Nov 2025
$3.28
$4.51
+42.72%

ANNX Share Price FAQs